RBC Capital Keeps Their Buy Rating on Elevance Health (ELV)
In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on Elevance Health (ELV – Research Report), with a price ...
RBC Capital Reaffirms Their Hold Rating on Discover Financial Services (DFS)
In a report released yesterday, Jon Arfstrom from RBC Capital maintained a Hold rating on Discover Financial Services (DFS – Research Report), ...
RBC upgrades JPMorgan stock target on strong Q4 results
RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price ...
RBC Capital cuts Intra-Cellular stock rating, hikes target to $132
RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...
MAA price target lowered to $158 from $165 at RBC Capital
RBC Capital analyst Brad Heffern lowered the firm’s price target on MAA (MAA) to $158 from $165 and keeps a Sector Perform rating on the shares. The firm updated residential real estate investment ...